<h1>Pharmaceutical Innovation Debate: India Challenges Patent Claims, Affirms Commitment to IP Rights and Market Access</h1> Indian commerce minister defended domestic pharmaceutical firms against allegations of intellectual property rights violations. He stated that Swiss pharmaceutical companies have not provided evidence of copied products or technologies. The minister emphasized India's respect for intellectual property rights and highlighted legal provisions preventing patent evergreening. He suggested that pharmaceutical companies from Switzerland and other countries can benefit from India's large market by offering affordable products while maintaining innovation standards.